Showing 261-270 of 1564 results for "".
Taking Stock of the Latest Developments in Myopia
https://modernod.com/topics/myopia/taking-stock-of-the-latest-developments-in-myopia/38829/A what’s what of surgical and nonsurgical treatment options, as well as new diagnostic tools and company outreach efforts.What’s New and What’s Coming in OSD Treatment
https://modernod.com/topics/ocular-surface/whats-new-and-whats-coming-in-osd-treatment/38578/An overview of recent FDA approvals and potential new therapies.Preoperative Considerations in Cataract Surgery
https://modernod.com/mod-issues/2021-oct/preoperative-considerations-in-cataract-surgery/38309/Key Elements in Handing Off the Surgical Glaucoma Patient
https://modernod.com/topics/glaucoma/key-elements-in-handing-off-the-surgical-glaucoma-patient/38184/Provide complete documentation to the surgeon and offer clear, accurate information to the patient.Is it Glaucoma? Perimetry Cracked the Case
https://modernod.com/topics/glaucoma/is-it-glaucoma-perimetry-cracked-the-case/54303/Advanced imaging can be very useful, but don’t neglect this tried-and-true diagnostic tool when differentiating nonglaucomatous etiologies.Systemic Comorbidities and Ocular Surface Dryness
https://modernod.com/topics/ocular-surface/systemic-comorbidities-and-ocular-surface-dryness/38260/Taking a thorough systemic case history can prompt eye care providers to screen patients for ocular surface issues.The Myopia Pandemic
https://modernod.com/mod-issues/2022-mar/the-myopia-pandemic/39126/Research into efforts to control this condition.Reflecting Back, Giving Forward
https://modernod.com/mod-issues/2022-nov-dec/reflecting-back-giving-forward/38522/The Importance of Collaborative Care for Patients With Diabetic Retinopathy
https://modernod.com/topics/retina/the-importance-of-collaborative-care-for-patients-with-diabetic-retinopathy/38027/Long-Awaited Treatment for Demodex Blepharitis Receives FDA Approval
https://modernod.com/topics/ocular-surface/long-awaited-treatment-for-emdemodexem-blepharitis-receives-fda-approval/38645/The twice-daily prescription drop will be available by end of August 2023.